China Universal Asset Management Company’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.4K | Buy |
17,541
+504
| +3% | +$1.88K | 0.01% | 398 |
|
|
2025
Q1 | $47K | Sell |
17,037
-973
| -5% | -$2.69K | ﹤0.01% | 423 |
|
|
2024
Q4 | $99.8K | Buy |
18,010
+4,475
| +33% | +$24.8K | 0.01% | 390 |
|
|
2024
Q3 | $113K | Buy |
13,535
+5,935
| +78% | +$49.5K | 0.01% | 347 |
|
|
2024
Q2 | $51.8K | Sell |
7,600
-4,289
| -36% | -$29.2K | 0.01% | 352 |
|
|
2024
Q1 | $78K | Buy |
11,889
+4,742
| +66% | +$31.1K | 0.01% | 391 |
|
|
2023
Q4 | $46.4K | Buy |
7,147
+5,587
| +358% | +$36.3K | 0.01% | 376 |
|
|
2023
Q3 | $7.85K | Buy |
1,560
+817
| +110% | +$4.11K | ﹤0.01% | 360 |
|
|
2023
Q2 | $6.5K | Buy |
743
+72
| +11% | +$630 | ﹤0.01% | 343 |
|
|
2023
Q1 | $7.95K | Buy |
671
+288
| +75% | +$3.41K | ﹤0.01% | 323 |
|
|
2022
Q4 | $3.9K | Buy |
383
+30
| +8% | +$305 | ﹤0.01% | 323 |
|
|
2022
Q3 | $2K | Buy |
+353
| New | +$2K | ﹤0.01% | 360 |
|